Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

NCT06592664 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Management Decision

Conditions

Pancreas Cancer
Pancreatic Carcinoma
Pancreas Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Unresectable Pancreatic Cancer
Metastatic Pancreatic Cancer
PDAC
PDAC - Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: certepetide
DRUG: nab-paclitaxel
DRUG: gemcitabine
DRUG: placebo matching certepetide
DRUG: certepetide
DRUG: placebo matching certepetide
DRUG: placebo matching certepetide

Sponsor

Lisata Therapeutics, Inc.